Topical 5-fluorouracil 1% for moderate to extensive ocular surface squamous neoplasia in 73 consecutive patients: Primary versus secondary treatment.
Irwin LeventerHartej SinghBahram PashaeeChristian D RaimondoChenab K KhakhJonathan L MartinBinod AcharyaQiang ZhangSara E LallyCarol L ShieldsPublished in: Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) (2024)
Topical 5FU 1% is efficacious and safe as a primary or secondary treatment for moderate to extensive OSSN. Tumors treated with primary 5FU 1% demonstrated more complete resolution. In patients with moderate to extensive OSSN, primary treatment with topical 5FU 1% may be warranted.